2011 July - December - nuhcs

More documents

Recommendations

Info

abstractsASCVTS-ATCAS 2011: Joint Meeting of 19thASCVTS & 21st ATCSAPhuket, Thailand, May 20111. Is Continuation of Anti-Platelet Therapy Until CoronaryArtery Bypass Grafting a Safe Strategy? Zaw MT, Hu J,Tay CW, Ng WQ, Chia D, Lee CN, Kofidis T2. Sutureless Valve Technology Facilitates Aortic ValveReplacement Through Right Minithoracotomy.Grunenfelder J, KofidisT, Reser D, Emmert M, PlassA, Falk V.3. Post-CABG Atrial Fibrillation: Is Single/Dual AntiplateletTherapy as Safe and Effective as Anticoagulation Therapyin Preventing Major Thromboembolic Events? Ooi OC,Yang J, Luo HD, Lee CN.International Student Congress of (bio)MedicalSciencesGroningen, Netherlands, June 20111. First Prize for Best Presentation, Cardiology & PulmonaryTrack session. Ethnic differences in risk prediction forheart failure rehospitalization. Zaw MW, Wong CC,Seow SC, Chai P, Kwok B, Ng K, Ling LF, Leong G,Yeo D, Surrun SK, Sim LL, Gao F, Lam SP.The Lancet/JACC 1st Asia PacificCardiovascular SummitHong Kong, July 20111. Growth Differentiation Factor 15, ST2 and NatriureticPeptides in Heart Failure With Preserved VersusReduced Ejection Fraction. Santhanakrishnan R, ChongJ, Richards AM, Lam SP.European Society of Cardiology 2011Paris, France, August 20111. Safety of deferring revascularization in lesions with FFR>0.75 but a small IVUS-derived lumen area. JunagadeS, Chan MY, Low AF, Teo SG, Richards AM, Yeo TC,Tan HC, Lee CH.2. Long-term clinical outcomes of medical therapy versuscoronary revascularisation in patients with intermediatestenoses guided by pressure wire. Shi HY, Chan MY,Low AF, Lee CH, Teo SG, Chan KH, Sethi R, RichardsAM, Tan HC.3. Wide fluctuations in capillary glucose levels during acutecoronary syndrome predicts poor prognosis. Lee GK,Yeo WT, Chan MY, Poh KK, Lau CS, Lee RC, Yeo TC.4. Novel assessment of vortex formation time of the rightventricle: comparison with left ventricular fluid dynamicsin pulmonary embolism. Reyes-Mariano M, Oinuma S,Soo WM, Loh JP, Yeo TC, Pooja J, Venkatesh SK, PohKK.5. Progression of impaired left ventricular contractility inpatients with isolated diastolic dysfunction and heartfailure with preserved ejection fraction. Zhong L, PohKK, Sia W, Lee LC, Le TT, Chua T, Tan RS.15th Annual Scientific meeting of the HeartFailure Society of AmericaBoston, United States, September 20111. Ethnic differences in risk prediction for heart failurerehospitalization. Zaw MW, Wong CC, Seow SC, ChaiP, Kwok B, Ng K, Ling LF, Leong G, Yeo D, Surrun SK,Sim LL, Gao F, Lam SP.NUHCS PULSE | 26
Western Vascular Society 26th AnnualMeetingHawaii, United States, September 20111. Characterization of Thoracic Aortic Arch Anatomy inthe Asian Elderly Population. Ho P, Chiu PX, Lee HP,Venkatesh SK.12th Asian Society for Vascular Surgery(ASVS 2011)Taipei, Taiwan, September 20111. Reliability of Using Ultrasound Duplex for Screeningof Dysfunctional Hemodialysis Access2. Raju A, Kyin KM, Zaw MT, Canlas CC, Seah MH,Serrano C, Hartman M, Ho P.American Heart Association Scientific Sessions,Orlando, United States, November 20111. Sex differences in clinical characteristics and outcomesin elderly patients with heart failure and preservedejection fraction: The I-PRESERVE Trial. Lam SP,Anand IS, Carson PE, Massie BM, Rector T, KuskowskiM, McKelvie R, MZile MR, McMurray JJ, Komajda M,Kitzman DW.2. Growth Differentiation Factor 15, ST2 and NatriureticPeptides in Heart Failure with Preserved VersusReduced Ejection Fraction. Santhanakrishnan R, ChongJ, Richards AM, Lam SP.3. Comparing the Effects of Low-Flow Aortic Stenosiswith Preserved Ejection Fraction Versus Normal-FlowAortic Stenosis on Left Ventricular Diastolic Functionand Left Atrial Volumes. Soo WM, Ling LH, Chan MY,Loh J, Poh KK.Transcatheter Cardiovascular Therapeutics2011San Francisco, United States, October 2011American Society of Echocardiography 22ndAnnual Scientific SessionsMontreal, June 20111. Real-World Comparison Of Clinical Outcomes OfPatients Who Received New Generation PlatinumChromium Everolimus-Eluting Stent Versus CobaltChromium Everolimus-Eluting Stent. Li RG, Low AF,Lee CH, Chan MY, Teo SG, Chan KH, Richards AM,Tan HC.1. Suboptimal left ventricular vertical formation and fluidpropagation in mitral valve stenosis. Loh JP, Yeo TC,Poh KK.NUHCS PULSE | 27
Page 2 and 3: in this issue02 (Clinical Vignettes
Page 5 and 6: Fortunately modern and available tr
Page 7 and 8: The “Hybrid” operating theatre
Page 9 and 10: What isOptical CoherenceTomography?
Page 11 and 12: We had the pleasure and privilege o
Page 13 and 14: and handsome men from among our col
Page 15 and 16: Bioabsorbable Stent:A/Prof Tan Huay
Page 17 and 18: ESC 2011Dr YeoTee JooI recently att
Page 19 and 20: The new P2Y12 - inhibiiting drugs,
Page 21 and 22: happeningsMO dinner 24 Oct 2012Card
Page 23 and 24: publications1. Annals of Vascular D
Page 25: 38. Am J Med. 2011 Nov;124(11):1051

2011 July - December - nuhcs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?